Arsenic Toxicity: A Clinical Guide for Providers

Written by Empire Medical Training Editorial Team

Medically reviewed by Peter Bongiorno, ND, LAc Naturopathic Doctor & Licensed Acupuncturist; Integrative & Functional Medicine

Updated June 2026 ·11 min read

Arsenic occupies an unusual place in the conversation about heavy metal toxicity. Historically it was even used in medicine — as an antisyphilitic agent — yet it is also a recognized human carcinogen. The reason both statements can be true is that “arsenic” is not one substance. Its toxicity depends almost entirely on the form involved, and for clinicians that distinction is the single most important thing to understand before ordering a test or treating a patient.

This guide is written for providers who want an accurate, practical overview grounded in clinical reasoning rather than fear. It is clinical education, not medical advice, and nothing here is a treatment protocol or a substitute for evaluation by a qualified clinician. Significant acute arsenic poisoning is a medical emergency and warrants immediate referral.

What is arsenic toxicity?

Arsenic exists in two broad forms, and the difference is clinically decisive. Inorganic arsenic is the toxic form and the one that drives the disease and cancer risk providers worry about. Organic arsenic, the form bound up in many of the foods we eat — particularly seafood — is generally considered non-toxic and is excreted relatively readily. When this page refers to arsenic toxicity, it means inorganic arsenic; failing to keep the two apart is the most common source of confusion, both in counseling patients and, as we will see, in interpreting lab results.

Toxicity also presents along two timelines. Acute toxicity follows a large single exposure and tends to announce itself through dramatic gastrointestinal symptoms. Chronic toxicity is the quieter and, in practice, far more common scenario: persistent low-level exposure — frequently through drinking water — that accumulates over months and years and surfaces as skin changes, neuropathy, and elevated long-term cancer risk. Much of what a functional or integrative clinician encounters falls into this chronic, lower-dose category, which is precisely the territory that conventional industrial toxicology, focused on overt poisoning, tends to overlook.

Sources of arsenic exposure

For most people, the single largest source of inorganic arsenic is contaminated well or ground water. Arsenic occurs naturally in rock and soil and leaches into aquifers, so private wells in affected regions can deliver a steady, unmonitored dose for years. Because this exposure is invisible and continuous, water is the first place to look when chronic arsenic toxicity is suspected.

Diet is the next major contributor. Rice and rice products are notable because rice readily takes up arsenic from soil and water; imported rice — for example from parts of Asia — has tended to carry higher levels than domestically grown rice, though regional conditions and contamination shift this picture over time. Apple juice and some shellfish can also contribute. Here the organic-versus-inorganic distinction matters again: much of the arsenic in seafood is the organic, lower-concern form, which is reassuring clinically but, as the testing section explains, complicates urine interpretation.

Finally, there are occupational and environmental sources: pesticides and insecticides have historically been among the highest-exposure routes, alongside cigarette smoke, ceramics, and metalwork. For a fuller map of how heavy metals enter the body across all the major exposure routes, see our overview of the sources of heavy metal exposure.

How arsenic harms the body

At the cellular level, arsenic is fundamentally an enzyme and metabolic disruptor. Like other toxic metals, it has a high affinity for the sulfur-containing (thiol) groups that many essential enzymes depend on, and binding there blocks the proteins responsible for normal cellular metabolism. Inorganic arsenic interferes with energy production and, importantly, contributes to oxidative damage of DNA — a mechanism it shares with cadmium, mercury, and lead. That DNA-level injury is the bridge to its most serious property.

Arsenic is a recognized human carcinogen. This reframes the clinical stakes: chronic arsenic exposure is not merely a quality-of-life issue but a long-term oncologic one, which is part of a broader, relatively recent shift toward recognizing cancer risk as a genuine consequence of heavy metal burden rather than a fringe concern. The same enzymatic and oxidative disruption that damages DNA also helps explain arsenic's reach across multiple organ systems.

Clinically, the downstream effects cluster in three areas. Skin is a hallmark target — arsenic produces characteristic pigmentation changes and nail findings, in part because of its affinity for keratin. Cardiovascular effects follow from arsenic's contribution to oxidative stress and endothelial dysfunction, the same inner-blood-vessel injury that links several heavy metals to hypertension and vascular disease. And neurological effects — most recognizably a peripheral neuropathy with numbness and tingling — reflect arsenic's disruption of nerve metabolism. That tingling, worth noting, is frequently misattributed to anxiety before a metal source is ever considered.

Symptoms of arsenic poisoning

The symptom picture tracks the acute-versus-chronic split. Acute arsenic poisoning is dominated by gastrointestinal distress — abdominal pain, vomiting, and diarrhea — which can be severe and, in significant exposures, life-threatening; this is the emergency scenario that belongs in urgent care, not a wellness work-up.

Chronic, lower-level exposure is more insidious and more likely to land in a primary care or functional medicine office without arsenic ever being suspected. Watch for:

• Skin changes — altered pigmentation and characteristic nail findings, including transverse lines across the nails (sometimes called Mees’ lines) that reflect arsenic's affinity for keratin.
• Gastrointestinal symptoms — lower-grade and more persistent than the acute picture, easy to attribute to other causes.
• Peripheral neuropathy — numbness and a prickly, tingling sensation in the hands and feet, a finding commonly misread as anxiety rather than a toxic exposure.

Because these symptoms overlap heavily with many other conditions, arsenic toxicity is one of the metal exposures that most often hides in plain sight. When a patient's presentation is not explained by the usual work-up — particularly an unexplained neuropathy paired with skin or nail changes — heavy metals deserve a place on the differential. For the broader pattern across all metals, see the guide to heavy metal toxicity symptoms.

Testing for arsenic

Testing strategy depends on whether you are chasing recent or long-term exposure. For recent or acute exposure, whole blood or a 24-hour urine collection is appropriate; a 24-hour urine is generally the better window on a recent exposure than a spot sample. For long-term exposure, arsenic's affinity for keratin makes hair or fingernail testing useful, since the metal concentrates there and reflects a longer time horizon.

There is one caveat too important to soften: standard urine arsenic testing does not distinguish toxic inorganic arsenic from harmless organic arsenic. A patient who recently ate shellfish or other seafood can post a strikingly elevated total urine arsenic that reflects benign organic arsenic, not a toxic burden — the classic seafood confounder. The honest, practical move is to account for recent seafood intake before acting on a result, and to use speciated testing or repeat sampling after a seafood-free interval when the distinction matters. Treating a seafood-driven number as if it were inorganic toxicity is a real and avoidable error.

A related point on provoked (“challenge”) urine testing, in which a chelator is given to mobilize stored metals before collection: this approach is controversial and not standardized. Provoked tests reliably produce higher numbers — nearly everyone carries some metal burden, so post-challenge values rise even in people without complaints — which makes them easy to over-interpret. The clinically grounded question is never simply “is arsenic detectable” but “is this exposure plausibly driving this patient's illness,” answered by triangulating a credible source, a fitting symptom pattern, and lab detection together. For a fuller treatment of methods and their interpretation, see heavy metal testing.

Treatment of arsenic toxicity

The first and most important intervention is the least glamorous: remove the source. For arsenic, that overwhelmingly means addressing water — identifying and filtering or replacing a contaminated supply — along with adjusting dietary contributors such as rice. No detoxification strategy succeeds while the exposure continues, and in many chronic cases source removal alone, supported by the body's own excretory pathways, is the substance of the work.

For significant, documented toxicity, chelation — using agents that bind arsenic into non-toxic complexes for excretion — is the established treatment. This page stays deliberately conceptual: the appropriate agents, routes, dosing, and monitoring for arsenic are exactly the protocol-level material taught in Empire's course, not a general web page. What providers should carry away here is the clinical posture. Chelation is genuinely useful for confirmed, meaningful heavy metal poisoning, but it carries real risks — depletion of essential minerals such as zinc and magnesium, kidney and liver stress, and the mobilization of metals out of storage that can transiently make a patient feel worse — so it demands careful patient selection and monitoring rather than routine use.

Equally important is what chelation is not supported for. It is not an evidence-based treatment for general “detox,” for autism, or for cardiovascular disease as a population strategy — the large NIH-funded TACT trial of EDTA chelation produced a modest and much-debated signal that does not justify marketing chelation as cardiovascular prevention. Honest practice means confirming real toxicity before treating, avoiding the unproven “detox” marketing that surrounds this space, and referring acute poisoning for emergency care. For how clinicians think about chelation in depth, see chelation therapy; supportive antioxidant approaches such as glutathione IV therapy are sometimes used alongside, since glutathione protects cells from the reactive oxygen species associated with heavy metals.

Training for providers

Arsenic is a useful case study in why this work rewards structured education. The judgment calls — separating the toxic inorganic form from benign organic arsenic, reading a urine result without being fooled by last night's shellfish, weighing a credible source against an ambiguous symptom, and deciding whether source removal alone is enough or chelation is warranted — are not things a single article can substitute for. They are taught, with the underlying science and the clinical reasoning, in a dedicated course.

Empire Medical Training's Heavy Metals and Chronic Illness course, taught by Dr. Peter Bongiorno, ND, situates arsenic within the full landscape of heavy metal toxicity — mechanisms, testing, and treatment — so clinicians can evaluate and manage these patients responsibly and integrate the approach into a functional or anti-aging practice.